NCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
Mayo Clinic
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Alliance for Clinical Trials in Oncology
Stanford University
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
Northwestern University
UNICANCER